| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-06 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |